Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Triggers of Ventricular Arrhythmias (TOVA) Study

This study has been completed.
Sponsor:
Information provided by:
National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier:
NCT00005243
First received: May 25, 2000
Last updated: January 3, 2006
Last verified: December 2005
  Purpose

To investigate factors which trigger the discharge of implantable cardioverter-defibrillators (ICDs).


Condition
Cardiovascular Diseases
Arrhythmia
Myocardial Infarction
Heart Diseases

Study Type: Observational

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Study Start Date: April 1989
Estimated Study Completion Date: August 2004
  Show Detailed Description

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

No eligibility criteria

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00005243

Sponsors and Collaborators
Investigators
Investigator: James Muller Massachusetts General Hospital
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00005243     History of Changes
Other Study ID Numbers: 1124
Study First Received: May 25, 2000
Last Updated: January 3, 2006
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cardiovascular Diseases
Heart Diseases
Infarction
Myocardial Infarction
Ischemia
Myocardial Ischemia
Necrosis
Pathologic Processes
Vascular Diseases

ClinicalTrials.gov processed this record on November 20, 2014